Rocket


Overview
Financials
News + Filings

 
 

Acumen Pharmaceuticals, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19
Revenues8.08.6
            Revenue growth-6.8% 
Cost of goods sold14.615.5
Gross profit-6.6-6.9
            Gross margin-82.0%-80.2%
General and administrative1.40.9
EBIT-7.9-7.8
            EBIT margin-98.9%-91.0%
Pre-tax income-7.3-7.9
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income0.00.0
            Net margin-0.1%-0.1%
 
Diluted EPS($11.73)($11.97)
Shares outstanding (diluted)0.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy